-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Evelo Biosciences, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2016 to 2022.
- Evelo Biosciences, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was -$199K, a 270% decline year-over-year.
- Evelo Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $81.7M, a 16.3% decline from 2021.
- Evelo Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $97.5M, a 49% increase from 2020.
- Evelo Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $65.5M, a 1211% increase from 2019.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)